Wednesday, January 20, 2010

FDA approves HeartMate II for severe heart failure

The FDA has announced that they have approved the HeartMate II, a continuous-flow, left ventricular assist system as a support for severe heart failure patients who are not acceptable candidates for heart transplantation. The HeartMate II is already FDA-approved for use in patients awaiting further, perhaps more complex treatment, such as transplants.
“The approval of HeartMate II provides an option for heart failure patients who cannot receive a transplant,” said Jeffrey Shuren, M.D., director of the FDA’s Center for Devices and Radiological Health. “Its smaller size and mobility should allow more patients, including women and men of smaller stature, access to treatment.”
HeartMate II is manufactured by Thoratec Corp. based in Pleasanton, Calif.

To read the full FDA press release, click here.

No comments:

Post a Comment